Skip to content

Study · Animal study (in vivo) · mouse · 2026

5 results

MOTS-c attenuates cardiac dysfunction following high altitude exposure by promoting mitophagy.

Feng Z, Xing Y, Lou J, Li H, Zhang Z, Li M, Zhu Q, Cui Y, Li J, Gao F, Yi W, Sun Y, Zhang X

Free radical biology & medicine5 Feb 2026Cited by 1 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study5

3 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In mice, exogenous MOTS‑c supplementation during de-acclimatization alleviated cardiac dysfunction after high-altitude exposure.

    In plain wordsIn mice, giving MOTS‑c after return from high altitude reduced heart problems caused by high altitude.

    Peptide
    MOTS-c
    Outcome
    DecreaseCardiac dysfunction after high-altitude exposure
    Study

    mousen: not reported in source

    High-altitude exposure and de-acclimatization model
    Outcome group
    Heart function · Cardiovascular
    Studied dose
    Dose not stated · During de-acclimatizationAs given in this study (mouse).

    Source sentences

    Summary
    Exogenous supplementation of MOTS-c during de-acclimatization effectively alleviated the cardiac dysfunction post HA exposure.
    1 context sentence
    Summary · context
    In this study, mice were subjected to a decompression chamber to simulate a 6000-m altitude exposure for 10 days, followed by the other 10-day de-acclimatization period at a lower altitude of 400 m.
  2. 02AnimalAnimal study (in vivo)Mechanism

    In mice, MOTS‑c activated the Pink1/Parkin pathway, promoting mitophagy and improving mitochondrial quality.

    In plain wordsIn mice, MOTS‑c switched on a cell-cleaning pathway (Pink1/Parkin) and improved mitochondrial quality.

    Peptide
    MOTS-c
    Outcome
    IncreasePink1/Parkin pathway, mitophagy and mitochondrial quality
    Study

    mousen: not reported in source

    High-altitude exposure and de-acclimatization model
    Outcome group
    Mitochondrial function · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Mechanistically, MOTS-c activated the PTEN-induced putative kinase 1 (Pink1)/Parkin pathway, promoting mitophagy and improving mitochondrial quality.
  3. 03AnimalAnimal study (in vivo)Mechanism

    In mice, silencing Pink1 abolished the protective effects of MOTS‑c during de-acclimatization.

    In plain wordsIn mice, when Pink1 was silenced, MOTS‑c no longer protected the heart during return from high altitude.

    Peptide
    MOTS-c
    Outcome
    No significant changeMOTS-c protection with Pink1 silencing
    Study

    mousen: not reported in source

    High-altitude exposure and de-acclimatization model
    Comparator
    Without Pink1 silencing
    Outcome group
    Receptor activity and mechanism · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Silencing Pink1 abolished the protective effects of MOTS-c during de-acclimatization.

Natural levels measured2

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 04HumanEndogenous levelObservational studyOther

    Circulating MOTS‑c levels were reduced in patients with high altitude heart disease and acute coronary syndrome.

    In plain wordsPeople with high altitude heart disease or acute coronary syndrome had lower levels of the body's own MOTS‑c in the blood.

    Peptide
    MOTS-c
    Outcome
    DecreaseCirculating MOTS-c in high altitude heart disease and acute coronary syndrome
    Study

    n: not reported in source

    Outcome group
    Mitochondrial function · Cardiovascular

    Source sentences

    Summary
    Additionally, reduced circulating MOTS-c levels were observed in patients with high altitude heart disease and acute coronary syndrome.

    This result measures the body's own MOTS-c. Nobody was given the peptide. It is not evidence about taking it.

  2. 05AnimalEndogenous levelAnimal study (in vivo)Other

    In mice after high-altitude exposure, cardiac dysfunction persisted through de-acclimatization together with sustained mitochondrial dysfunction and MOTS‑c deficiency.

    In plain wordsIn mice, heart problems after high altitude lasted after return to low altitude, together with low levels of the body's own MOTS‑c.

    Peptide
    MOTS-c
    Outcome
    DecreaseMOTS-c deficiency after high-altitude exposure
    Study

    mousen: not reported in source

    High-altitude exposure and de-acclimatization model
    Outcome group
    Mitochondrial function · Cardiovascular

    Source sentences

    Summary
    The cardiac dysfunction induced by HA exposure persisted throughout the de-acclimatization, accompanied with sustained mitochondrial dysfunction and the short peptide mitochondrial open reading frame of the 12S ribosomal RNA type-c (MOTS-c) deficiency.
    1 context sentence
    Summary · context
    In this study, mice were subjected to a decompression chamber to simulate a 6000-m altitude exposure for 10 days, followed by the other 10-day de-acclimatization period at a lower altitude of 400 m.

    This result measures the body's own MOTS-c. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    10 Oct 2026, 08:19 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:47 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.